Randomized Controlled Trial of Pirfenidone in Patients With Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis
Latest Information Update: 20 Jan 2020
At a glance
- Drugs Pirfenidone (Primary)
- Indications Interstitial lung diseases
- Focus Therapeutic Use
- 13 Jul 2016 New trial record